354 results on '"Green, Michael D."'
Search Results
2. Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer
3. Impact of commonly prescribed medications on immune-related adverse events.
4. Effect of common medications on immune checkpoint inhibitor efficacy.
5. Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
6. Calculating quasinormal modes of extremal and nonextremal Reissner-Nordström black holes with the continued fraction method
7. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
8. A 30-Year-Old Male Chinese Trader With Fever in Laos
9. List of Contributors
10. Everyday discrimination and age-related trajectories of blood pressure among Black and White middle-aged and older adults.
11. PIKfyve controls dendritic cell function and tumor immunity
12. Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer
13. Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
14. Epstein-Barr virus and posttransplant lymphoproliferative disorder
15. Donor screening and donor-derived infections
16. Preface
17. Contributors
18. Multi‐Trajectories of Blood Pressure and Cognitive Function in U.S. Adult Population
19. 920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
20. 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
21. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
22. Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer
23. United States
24. Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers
25. Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
26. Professor Francis Hermann Bohlen (1868–1942)
27. Abstract 2823: Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor immune microenvironment
28. Supplemental Information from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
29. Supplemental Figures 1-6 from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
30. Data from DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
31. Figure S2 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
32. Data from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
33. Supplemental Figures 1-6 from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
34. Supplemental Information from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
35. Figure S3 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
36. Data from DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
37. Supplementary Figure from DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
38. Data from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
39. Figure S2 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
40. Data from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
41. Figure S1 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
42. Table S1 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
43. Figure S1 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
44. Figure S4 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
45. Table S1 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
46. Figure S3 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
47. Figure S4 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
48. Data from Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
49. Public reporting of black participation in anti-hypertensive drug clinical trials
50. Supplementary Figure 1-4 from Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.